MARKET

ILMN

ILMN

Illumina
NASDAQ

Real-time Quotes | Nasdaq Last Sale

456.16
+0.81
+0.18%
Pre Market: 462.00 +5.84 +1.28% 09:09 06/21 EDT
OPEN
453.28
PREV CLOSE
455.35
HIGH
460.48
LOW
450.72
VOLUME
108
TURNOVER
--
52 WEEK HIGH
555.77
52 WEEK LOW
260.42
MARKET CAP
66.60B
P/E (TTM)
106.99
1D
5D
1M
3M
1Y
5Y
Illumina Inc. stock outperforms market on strong trading day
marketwatch.com · 2d ago
Why Moderna, Illumina, or China’s Meituan Could Be the Next Tesla
marketwatch.com · 2d ago
5 things to know before the stock market opens Friday
U.S. stock futures fell Friday as the Dow looks to avoid its first five-session losing streak since January.
CNBC.com · 3d ago
Worldwide Next Generation Sequencing Industry to 2025 - Competitive Analysis and the Impact of COVID-19
/PRNewswire/ -- The report has been added to offering.
PR Newswire - PRF · 3d ago
Illumina Inc. stock rises Thursday, outperforms market
marketwatch.com · 3d ago
Hedge Funds Are Buying Illumina, Inc. (ILMN)
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At Insider Monkey, we follow nearly 900 active hedge funds and no...
Insider Monkey · 3d ago
EU antitrust regulators set July 27 deadline for Illumina, Grail deal
reuters.com · 4d ago
Illumina Inc. stock underperforms Wednesday when compared to competitors
marketwatch.com · 4d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ILMN. Analyze the recent business situations of Illumina through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 20 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ILMN stock price target is 410.18 with a high estimate of 520.00 and a low estimate of 300.00.
EPS
Institutional Holdings
Institutions: 1.35K
Institutional Holdings: 139.00M
% Owned: 95.20%
Shares Outstanding: 146.00M
TypeInstitutionsShares
Increased
369
7.08M
New
141
922.21K
Decreased
343
6.96M
Sold Out
77
2.07M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.62%
Healthcare Equipment & Supplies
-0.86%
Key Executives
Non-Executive Chairman/Independent Director
John Thompson
President/Chief Executive Officer/Director
Francis deSouza
Chief Financial Officer
Sam Samad
Chief Operating Officer
Robert Ragusa
Chief Human Resource Officer
Aimee Hoyt
Senior Vice President
Joydeep Goswami
Chief Technology Officer
Alex Aravanis
Chief Accounting Officer/Vice President
Jose Torres
Chief Marketing Officer
Kathryne Reeves
General Counsel/Secretary
Charles Dadswell
Other
Phillip Febbo
Other
Susan Tousi
Independent Director
Frances Arnold
Independent Director
Caroline Dorsa
Independent Director
Robert Epstein
Independent Director
Scott Gottlieb
Independent Director
Gary Guthart
Independent Director
Philip Schiller
Independent Director
Susan Siegel
No Data
About ILMN
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company's portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.

Webull offers kinds of Illumina, Inc. stock information, including NASDAQ:ILMN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ILMN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ILMN stock methods without spending real money on the virtual paper trading platform.